| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From The Johns Hopkins University School of Medicine (M.M.M., P.B.R, P.V.R, C.G.L.), Baltimore, MD; Utah State University (J.T., L.C., C.C., M.N., R.M.), Logan; Duke University Medical Center (K.M.H., K.A.W.-B.), Durham, NC; Boston University School of Medicine (R.C.G.), MA; and VA Puget Sound Health Care System and University of Washington School of Medicine (J.C.S.B.), Seattle.
Address correspondence and reprint requests to Dr. Michelle M. Mielke, Johns Hopkins University School of Medicine, Department of Psychiatry, Division of Geriatric Psychiatry and Behavioral Sciences, 550 N. Broadway, Suite 308, Baltimore, MD 21205 mmielke1{at}jhmi.edu
Background: While there is considerable epidemiologic evidence that cardiovascular risk factors increase risk of incident Alzheimer disease (AD), few studies have examined their effect on progression after an established AD diagnosis.
Objective: To examine the effect of vascular factors, and potential age modification, on rate of progression in a longitudinal study of incident dementia.
Methods: A total of 135 individuals with incident AD, identified in a population-based sample of elderly persons in Cache County, UT, were followed with in-home visits for a mean of 3.0 years (range: 0.8 to 9.5) and 2.1 follow-up visits (range: 1 to 5). The Clinical Dementia Rating (CDR) Scale and Mini-Mental State Examination (MMSE) were administered at each visit. Baseline vascular factors were determined by interview and physical examination. Generalized least-squares random-effects regression was performed with CDR Sum of Boxes (CDR-Sum) or MMSE as the outcome, and vascular index or individual vascular factors as independent variables.
Results: Atrial fibrillation, systolic hypertension, and angina were associated with more rapid decline on both the CDR-Sum and MMSE, while history of coronary artery bypass graft surgery, diabetes, and antihypertensive medications were associated with a slower rate of decline. There was an age interaction such that systolic hypertension, angina, and myocardial infarction were associated with greater decline with increasing baseline age.
Conclusion: Atrial fibrillation, hypertension, and angina were associated with a greater rate of decline and may represent modifiable risk factors for secondary prevention in Alzheimer disease. The attenuated decline for diabetes and coronary artery bypass graft surgery may be due to selective survival. Some of these effects appear to vary with age.
GLOSSARY: 3MS = revised Modified Mini-Mental State Examination for epidemiologic studies; AF = atrial fibrillation; CABG = coronary artery bypass graft surgery; CCHS = Copenhagen City Heart Study; CCSMHA = Cache County Study on Memory, Health, and Aging; CDR = Clinical Dementia Rating; CVD = cardiovascular disease; DM = diabetes mellitus; DPS = Dementia Progression Study; MI = myocardial infarction; MMSE = Mini-Mental State Examination; SBP = systolic blood pressure.
Supplemental data at www.neurology.org
Supported in part by R01 AG21136, R01 AG11380, R01 AG18712, and P01 AG05146 from the National Institute of Aging.
Disclosure: The authors report no conflicts of interest.
Presented in part as a poster at the 10th International Conference on AD and Related Disorders; Madrid, Spain; 2006.
Received February 21, 2007. Accepted in final form May 23, 2007.
This article has been cited by other articles:
|
|
 |
|
  E. van Exel, P. Eikelenboom, H. Comijs, M. Frolich, J. H. Smit, M. L. Stek, P. Scheltens, J. E. Eefsting, and R. G. J. Westendorp Vascular Factors and Markers of Inflammation in Offspring With a Parental History of Late-Onset Alzheimer Disease Arch Gen Psychiatry, November 1, 2009; 66(11): 1263 - 1270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sanz, S. Andrieu, A. Sinclair, H. Hanaire, B. Vellas, and For the REAL.FR Study Group Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease Neurology, October 27, 2009; 73(17): 1359 - 1366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Deschaintre, F. Richard, D. Leys, and F. Pasquier Treatment of vascular risk factors is associated with slower decline in Alzheimer disease Neurology, September 1, 2009; 73(9): 674 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Norton, K. W. Piercy, P. V. Rabins, R. C. Green, J. C. S. Breitner, T. Ostbye, C. Corcoran, K. A. Welsh-Bohmer, C. G. Lyketsos, and J. T. Tschanz Caregiver-Recipient Closeness and Symptom Progression in Alzheimer Disease. The Cache County Dementia Progression Study J Gerontol B Psychol Sci Soc Sci, September 1, 2009; 64B(5): 560 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Baranov, P. E. Bickler, G. J. Crosby, D. J. Culley, M. F. Eckenhoff, R. G. Eckenhoff, K. J. Hogan, V. Jevtovic-Todorovic, A. Palotas, M. Perouansky, et al. Consensus Statement: First International Workshop on Anesthetics and Alzheimer's Disease Anesth. Analg., May 1, 2009; 108(5): 1627 - 1630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Y. Takahashi, L. N. Dyrbye, K. G. Thomas, O. Quirindongo Cedeno, F. North, R. J. Stroebel, R. S. DeJesus, and P. V. Targonski The Association of Transient Ischemic Attack Symptoms With Memory Impairment Among Elderly Participants of the Third US National Health and Nutrition Examination Survey J Geriatr Psychiatry Neurol, March 1, 2009; 22(1): 46 - 51. [Abstract] [PDF]
|
|
|
|
 |
|
 E. P. Helzner, J. A. Luchsinger, N. Scarmeas, S. Cosentino, A. M. Brickman, M. M. Glymour, and Y. Stern Contribution of Vascular Risk Factors to the Progression in Alzheimer Disease Arch Neurol, March 1, 2009; 66(3): 343 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Viswanathan, W. A. Rocca, and C. Tzourio Vascular risk factors and dementia: How to move forward? Neurology, January 27, 2009; 72(4): 368 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Knecht, C. Oelschlager, T. Duning, H. Lohmann, J. Albers, C. Stehling, W. Heindel, G. Breithardt, K. Berger, E. B. Ringelstein, et al. Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy Eur. Heart J., September 1, 2008; 29(17): 2125 - 2132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Goette and R. C. Braun-Dullaeus Atrial fibrillation is associated with impaired cognitive function and hippocampal atrophy: silent cerebral ischaemia vs. Alzheimer's disease? Eur. Heart J., September 1, 2008; 29(17): 2067 - 2069. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
